Home Compare IVZ vs MRNA
Stock Comparison · Cheaper and stronger

Invesco vs Moderna: Which Stock Looks Stronger in 2026?

Invesco holds the cleaner structural position, with the lead spread across valuation and growth. Moderna does not offset that deficit through any equally strong structural edge elsewhere. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both valuation and growth materially support the lead. The overall score gap is 25 points in favour of Invesco Ltd..

Trajectory Similarity
0.65
Moderately similar
Peer-set rank: #4
within Invesco Ltd.'s functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The strongest overlap appears in capital structure and recent revenue growth.

Similarity drivers
capital structurerecent revenue growth
What reduces the match
margin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
IVZ
Invesco Ltd.
41
Peer-Score
Signal qualityMedium
vs
MRNA
Moderna, Inc.
16
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing and operating quality both support the lead here.

Dimension spread: IVZ vs MRNA Profitability 11 15 Stability 20 3 Valuation 88 30 Growth 36 9 IVZ MRNA
Gap Ranking
#1 Valuation +58
#2 Growth +27
#3 Stability +17
#4 Profitability +4
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for IVZ and MRNA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer IVZMRNA Relative valuation Structural strength

Invesco Ltd. looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses Forward P/E and peer-relative valuation score where available.

Relative Position vs Comparable Companies
Valuation
On valuation, Invesco Ltd. ranks near the top of the group; Moderna, Inc. sits in the weaker half.
Growth
Neither side looks especially strong on growth, though Invesco Ltd. still ranks somewhat higher.
Valuation — Dominant Gap
IVZ
88
MRNA
30
Gap+58in favour of IVZ

The peer-relative valuation gap is very wide, with the stronger side also looking meaningfully cheaper.

What else supports the lead

One company is still expanding while the other is contracting, which creates a very wide growth split.

What this means for the comparison

The lead is built on both valuation and growth, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the IVZ vs MRNA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-driven comparisons

Explore how IVZ and MRNA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.